Mixed lichenoid and psoriasiform drug eruption induced by rifampicin

Mixed lichenoid and psoriasiform drug eruption induced by rifampicin:

Abstract

Rifampicin is an essential first line anti‐tuberculosis drug. However, several cases of adverse reactions associated with this drug have been reported, the most common of which are cutaneous drug reactions. We report a case of mixed lichenoid and psoriasiform drug eruption induced by rifampicin.